DeepCRE: Revolutionizing Drug R&D with Cutting-Edge Computational Models

The author introduces DeepCRE as a novel computational model that significantly enhances Cross-drug Response Evaluation (CRE) in drug development, showcasing its potential to revolutionize therapeutic discovery and development.